House quashes Senate amendment to force drug price inclusion in pharma TV ads

Sticker prices in drug ads might be off the table again, thanks to some in the U.S. House of Representatives. The bipartisan amendment that included $1 million in funding to study and implement drug pricing in ads passed the Senate in late August but was stripped from a bill in the House of Representatives last week.